» Articles » PMID: 23388425

The Significance of Neutrophil/lymphocyte Ratio As a Possible Marker of Underlying Papillary Microcarcinomas in Thyroidal Goiters: a Pilot Study

Overview
Journal Am J Surg
Specialty General Surgery
Date 2013 Feb 8
PMID 23388425
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Preoperatively elevated neutrophil/lymphocyte ratio (NLR) is a negative prognostic factor of survival in various types of cancers. A retrospective study was conducted to examine if preoperative elevation of NLR is associated with higher risk for incidental papillary thyroid microcarcinoma (PTMC).

Methods: The study sample consisted of 26 patients with benign goiters, 31 patients with incidental PTMC, 26 patients preoperatively diagnosed with thyroid cancer, and 26 healthy controls. NLRs were compared regarding thyroidal pathology.

Results: The mean preoperative NLR was significantly elevated in patients with PTMC and thyroid cancer. In addition, the third and fourth quartiles of NLR included only patients with either PTMC or thyroid cancer. No significant differences in NLR occurred between patients with multifocal and unifocal PTMC.

Conclusions: NLRs were significantly elevated in patients with incidental PTMC and thyroid cancer. The findings of this pilot study indicate that NLR should be considered an easily accessible biomarker for detecting incidental PTCM; nevertheless, further studies are required to confirm these preliminary results.

Citing Articles

The Importance of Predictive Biomarkers and Their Correlation with the Response to Immunotherapy in Solid Tumors-Impact on Clinical Practice.

Mihaila R, Gheorghe A, Zob D, Stanculeanu D Biomedicines. 2024; 12(9).

PMID: 39335659 PMC: 11429372. DOI: 10.3390/biomedicines12092146.


Prognostic factors of papillary and follicular carcinomas based on pre-, intra-, and post-operative findings.

Ito Y, Miyauchi A Eur Thyroid J. 2024; 13(5).

PMID: 39213599 PMC: 11466271. DOI: 10.1530/ETJ-24-0196.


Neutrophil diversity is associated with T-cell immunity and clinical relevance in patients with thyroid cancer.

Lee S, Koo B, Sun P, Yi S, Choi N, Yoon J Cell Death Discov. 2024; 10(1):222.

PMID: 38719807 PMC: 11078953. DOI: 10.1038/s41420-024-01970-z.


Predicting coexisting thyroid cancer with primary hyperparathyroidism in an endemic region of multinodular goiter: evaluating the effectiveness of preoperative inflammatory markers.

Balbaloglu H, Tasdoven I, Buyukuysal M, Karadeniz E, Comert M, Karadeniz Cakmak G Ann Surg Treat Res. 2023; 105(5):290-296.

PMID: 38023432 PMC: 10648613. DOI: 10.4174/astr.2023.105.5.290.


EVALUATION OF PRE-ABLATION NLR AND LMR AS PREDICTORS OF DISTANT METASTASES IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.

Ge J, Guo X, Zhao W, Zhang R, Bian Q, Luo L Acta Endocrinol (Buchar). 2023; 19(2):215-220.

PMID: 37908873 PMC: 10614579. DOI: 10.4183/aeb.2023.215.